In US Hispanics, cancer remains leading cause of death
the ONA take:
Cancer remains the leading cause of death among Hispanics in the United States, according to an American Cancer Society report published in CA: A Cancer Journal for Clinicians.
In “Cancer Statistics for Hispanics/Latinos,” a comprehensive report published every 3 years, Rebecca Siegel, MPH, director of surveillance information for the American Cancer Society, and fellow researchers found that 125,900 new cancer cases and 37,800 cancer deaths are expected among Hispanics/Latinos living in the United States in 2015.
Cancer incidence rates are 20% lower and cancer death rates are 30% lower in Hispanics than in non-Hispanic whites due to a lower incidence rate of the four most common cancers (prostate, breast, lung, and colon).
However, Hispanics are at a higher risk for cancers associated with infectious agents, such as cancers of the stomach, liver, and cervix.
Lung cancer was found to be the leading cause of cancer death among Hispanic men, accounting for about 17%, or 1 in 6 deaths. According to 2015 estimates, liver cancer is expected to surpass colorectal cancer as the second leading cause of death in this population.
In Hispanic women, the leading cause of cancer death is breast cancer at a 16% death rate, followed by lung and colorectal cancers. Lung cancer death rates were found to be 70% lower in Hispanic women compared to non-Hispanic white women due to a lower prevalence of smoking.
Cancer death rates are declining at a rate of 2.4% per year in men, as well as 0.5% per year in women.
“The growth in the population of US residents of Hispanic origin is now driven primarily by births, not immigration, which will probably change the future cancer risk profile of this group,” said Siegel.
Cancer remains the leading cause of death among Hispanics in the U.S.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|